QUIDELORTHO CORP Accounts Receivable, Allowance for Credit Loss
QUIDELORTHO CORP (QDEL) had Accounts Receivable, Allowance for Credit Loss of $97.10 million as of 2025-12-28, per its 10-K filed 2026-02-19.
Financial Statements › Balance Sheet › Assets
us-gaap:AllowanceForDoubtfulAccountsReceivable · last filed 2026-02-19
- 2025-12-28: Accounts Receivable, Allowance for Credit Loss $97.10M.
- 2024-12-29: Accounts Receivable, Allowance for Credit Loss $99.60M.
- 2023-12-31: Accounts Receivable, Allowance for Credit Loss $91.80M.
- 2023-01-01: Accounts Receivable, Allowance for Credit Loss $89.10M.
| Period end | Accounts Receivable, Allowance for Credit Loss | Accounts Receivable, Allowance for Credit Loss as first filed |
|---|---|---|
| 2025-12-28 | $97.10M 10-K · filed 2026-02-19 | |
| 2024-12-29 | $99.60M 10-K · filed 2026-02-19 | |
| 2023-12-31 | $91.80M 10-K · filed 2026-02-19 | |
| 2023-01-01 | $89.10M 10-K · filed 2026-02-19 | |
| 2022-10-02 | $11.00M 10-Q · filed 2022-11-04 | |
| 2022-07-03 | $6.60M 10-Q · filed 2022-08-05 | |
| 2022-01-02 | $52.40M 10-K · filed 2025-02-27 | $1.70M 10-Q · filed 2022-08-05 |
| 2021-01-03 | $103.40M 10-K/A · filed 2024-08-01 | |
| 2019-12-29 | $15.90M 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |